AU7673991A - Method for treating fungal infection - Google Patents

Method for treating fungal infection

Info

Publication number
AU7673991A
AU7673991A AU76739/91A AU7673991A AU7673991A AU 7673991 A AU7673991 A AU 7673991A AU 76739/91 A AU76739/91 A AU 76739/91A AU 7673991 A AU7673991 A AU 7673991A AU 7673991 A AU7673991 A AU 7673991A
Authority
AU
Australia
Prior art keywords
fungal infection
treating fungal
treating
infection
fungal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU76739/91A
Inventor
Geoffrey Bainbridge Dreyer
Carrie Lynn Frey
Yigal Koltin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of AU7673991A publication Critical patent/AU7673991A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU76739/91A 1990-03-30 1991-03-28 Method for treating fungal infection Abandoned AU7673991A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50214990A 1990-03-30 1990-03-30
US502149 1990-03-30

Publications (1)

Publication Number Publication Date
AU7673991A true AU7673991A (en) 1991-10-30

Family

ID=23996566

Family Applications (1)

Application Number Title Priority Date Filing Date
AU76739/91A Abandoned AU7673991A (en) 1990-03-30 1991-03-28 Method for treating fungal infection

Country Status (2)

Country Link
AU (1) AU7673991A (en)
WO (1) WO1991015121A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5833946A (en) * 1995-06-06 1998-11-10 Bayer Corporation Dissemination of fungal infections: animal model and method of prophylaxis
US6486193B2 (en) 1998-12-31 2002-11-26 Aventis Pharmaceuticals Inc. 3-substituted pyrrolidines useful as inhibitors of matrix metalloproteinases
HUE030464T2 (en) * 2010-09-20 2017-05-29 Xellia Pharmaceuticals Aps Caspofungin composition
US20140256811A1 (en) 2013-03-05 2014-09-11 Ecolab Usa Inc. Efficient stabilizer in controlling self accelerated decomposition temperature of peroxycarboxylic acid compositions with mineral acids

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2106389B (en) * 1981-07-16 1985-07-17 Nat Res Dev The inhibition of growth in fungi
US4829054A (en) * 1987-04-13 1989-05-09 Miles Laboratories, Inc. Method of decreasing lung damage in a host following the onset of gram negative septicemia/endotoxemia
US4876241A (en) * 1987-05-22 1989-10-24 Armour Pharmaceutical Company Stabilization of biological and pharmaceutical products during thermal inactivation of viral and bacterial contaminants

Also Published As

Publication number Publication date
WO1991015121A1 (en) 1991-10-17

Similar Documents

Publication Publication Date Title
AU8949391A (en) Method for pattern recognition
AU7103191A (en) Method for executing trust-path commands
AU6932291A (en) Process for preparing copolyestercarbonates
AU7373591A (en) Method for treating emotional numbness
AU688337B2 (en) Novel method for preparing ergothioneine
AU2719392A (en) Method for treating etchant
AU629119B2 (en) Method for forming copper arsenate
AU7378691A (en) Cutting process
AU2979289A (en) Method for treating asthma
ZA945083B (en) Naphthyl derivative for treatment method
AU639571B2 (en) Method for integrated coating
AU7673991A (en) Method for treating fungal infection
EP0469915A3 (en) Figure processing method
EP0469918A3 (en) Figure processing method
EP0469914A3 (en) Figure processing method
AU9075291A (en) Method for rebelting tires
AU646074B2 (en) Method of treating poppy
EP0521160A4 (en) Method of drawing locus of tool.
AU6559194A (en) Method of treating hepatitis b infection
AU3974495A (en) Optical treatment method
AU4261793A (en) Wedge-welding method
AU5039193A (en) A method for processing meant
AU7307094A (en) Method for improving leather treatment
AU7108998A (en) Method for treating fungal infections
RU1785687C (en) Method for glossalgia treatment